Published online before print October 28, 2002, doi: 10.1161/01.CIR.0000038364.26310.BD
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:2659.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
Adrenocortical, Autonomic, and Inflammatory Causes of the Metabolic Syndrome
Nested Case-Control Study
From the International Centre for Health and Society, Department of Epidemiology and Public Health, University College London, England; Endocrinology Unit (B.R.W., R.A., J.R.S.), Western General Hospital, University of Edinburgh, Scotland; Institute of Psychiatry (A.P., S.C.), Bethlem Royal Hospital, London, England; Department of Medicine (A.R., G.D.O.L.), Royal Infirmary, University of Glasgow, Scotland; and Department of Community Psychiatry (S.A.S.), Queen Mary and Westfield College, London, England.
Correspondence to E.J. Brunner, PhD, International Centre for Health and Society, Department of Epidemiology and Public Health, University College London, 1-19 Torrington Place, London, England. E-mail e.brunner{at}ucl.ac.uk
Background— The causes of metabolic syndrome (MS), which may be a precursor of coronary disease, are uncertain. We hypothesize that disturbances in neuroendocrine and cardiac autonomic activity (CAA) contribute to development of MS. We examine reversibility and the power of psychosocial and behavioral factors to explain the neuroendocrine adaptations that accompany MS.
Methods and Results— This was a double-blind case-control study of working men aged 45 to 63 years drawn from the Whitehall II cohort. MS cases (n=30) were compared with healthy controls (n=153). Cortisol secretion, sensitivity, and 24-hour cortisol metabolite and catecholamine output were measured over 2 days. CAA was obtained from power spectral analysis of heart rate variability (HRV) recordings. Twenty-four-hour cortisol metabolite and normetanephrine (3-methoxynorepinephrine) outputs were higher among cases than controls (+ 0.49, +0.45 SD, respectively). HRV and total power were lower among cases (both -0.72 SD). Serum interleukin-6, plasma C-reactive protein, and viscosity were higher among cases (+0.89, +0.51, and +0.72 SD). Lower HRV was associated with higher normetanephrine output (r=-0.19; P=0.03). Among former cases (MS 5 years previously, n=23), cortisol output, heart rate, and interleukin-6 were at the level of controls. Psychosocial factors accounted for 37% of the link between MS and normetanephrine output, and 7% to 19% for CAA. Health-related behaviors accounted for 5% to 18% of neuroendocrine differences.
Conclusions— Neuroendocrine stress axes are activated in MS. There is relative cardiac sympathetic predominance. The neuroendocrine changes may be reversible. This case-control study provides the first evidence that chronic stress may be a cause of MS. Confirmatory prospective studies are required.
Key Words: norepinephrine • coronary disease • stress • metabolism • heart rate
Related Article:
Circulation 2002 106: 2634-2636.
This article has been cited by other articles:
 |
|
 |
|
  E. M. Goldbacher, J. Bromberger, and K. A. Matthews Lifetime History of Major Depression Predicts the Development of the Metabolic Syndrome in Middle-Aged Women Psychosom Med, April 1, 2009; 71(3): 266 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Dunn, B. Bleske, M. Dorsch, T. Macaulay, B. Van Tassell, and O. Vardeny Nutrition and Heart Failure: Impact of Drug Therapies and Management Strategies Nutr Clin Pract, February 1, 2009; 24(1): 60 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gozal, O. S. Capdevila, and L. Kheirandish-Gozal Metabolic Alterations and Systemic Inflammation in Obstructive Sleep Apnea among Nonobese and Obese Prepubertal Children Am. J. Respir. Crit. Care Med., May 15, 2008; 177(10): 1142 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Weigensberg, C. M. Toledo-Corral, and M. I. Goran Association between the Metabolic Syndrome and Serum Cortisol in Overweight Latino Youth J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1372 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Chandola, A. Britton, E. Brunner, H. Hemingway, M. Malik, M. Kumari, E. Badrick, M. Kivimaki, and M. Marmot Work stress and coronary heart disease: what are the mechanisms? Eur. Heart J., March 1, 2008; 29(5): 640 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Vaccarino, C. McClure, B. D. Johnson, D. S. Sheps, V. Bittner, T. Rutledge, L. J. Shaw, G. Sopko, M. B. Olson, D. S. Krantz, et al. Depression, the Metabolic Syndrome and Cardiovascular Risk Psychosom Med, January 1, 2008; 70(1): 40 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Futterman and L. Lemberg Inequalities in the Healthcare System: A Problem, Worldwide Am. J. Crit. Care., November 1, 2007; 16(6): 617 - 620. [Full Text] [PDF]
|
|
|
|
 |
|
 B. R Walker Glucocorticoids and Cardiovascular Disease Eur. J. Endocrinol., November 1, 2007; 157(5): 545 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J-M Gonzalez-Clemente, C Vilardell, M Broch, A Megia, A Caixas, O Gimenez-Palop, C Richart, I Simon, A Martinez-Riquelme, J Arroyo, et al. Lower heart rate variability is associated with higher plasma concentrations of IL-6 in type 1 diabetes Eur. J. Endocrinol., July 1, 2007; 157(1): 31 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-F. O'Connor, S. J. Motivala, E. M. Valladares, R. Olmstead, and M. R. Irwin Sex differences in monocyte expression of IL-6: role of autonomic mechanisms Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R145 - R151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Bermudes, P. E. Keck Jr., and J. A. Welge The Prevalence of the Metabolic Syndrome in Psychiatric Inpatients With Primary Psychotic and Mood Disorders Psychosomatics, December 1, 2006; 47(6): 491 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhang, R. Niaura, J. R. Dyer, B.-J. Shen, J. F. Todaro, J. M. McCaffery, A. Spiro III, and K. D. Ward Hostility and Urine Norepinephrine Interact to Predict Insulin Resistance: The VA Normative Aging Study. Psychosom Med, September 1, 2006; 68(5): 718 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Paul-Labrador, D. Polk, J. H. Dwyer, I. Velasquez, S. Nidich, M. Rainforth, R. Schneider, and C. N. B. Merz Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med, June 12, 2006; 166(11): 1218 - 1224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Marmot Status Syndrome: A Challenge to Medicine JAMA, March 15, 2006; 295(11): 1304 - 1307. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Chandola, E. Brunner, and M. Marmot Chronic stress at work and the metabolic syndrome: prospective study BMJ, March 4, 2006; 332(7540): 521 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M Oltmanns, B. Dodt, B. Schultes, H. H Raspe, U. Schweiger, J. Born, H. L Fehm, and A. Peters Cortisol correlates with metabolic disturbances in a population study of type 2 diabetic patients Eur. J. Endocrinol., February 1, 2006; 154(2): 325 - 331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-H. Kim, M.-K. Kim, B. Y. Choi, and Y.-J. Shin Educational disparities in the metabolic syndrome in a rapidly changing society--the case of South Korea Int. J. Epidemiol., December 1, 2005; 34(6): 1266 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Innes, C. Bourguignon, and A. G. Taylor Risk Indices Associated with the Insulin Resistance Syndrome, Cardiovascular Disease, and Possible Protection with Yoga: A Systematic Review J Am Board Fam Med, November 1, 2005; 18(6): 491 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Lehman, S. E. Taylor, C. I. Kiefe, and T. E. Seeman Relation of Childhood Socioeconomic Status and Family Environment to Adult Metabolic Functioning in the CARDIA Study Psychosom Med, November 1, 2005; 67(6): 846 - 854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Lucini, G. Di Fede, G. Parati, and M. Pagani Impact of Chronic Psychosocial Stress on Autonomic Cardiovascular Regulation in Otherwise Healthy Subjects Hypertension, November 1, 2005; 46(5): 1201 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Greenberg, M. Henderson, S. Karim, and K. Holland-Elliott Does having an occupational mental health service make any difference? Occup. Med., October 1, 2005; 55(7): 549 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Liao, S. Takashima, N. Maeda, N. Ouchi, K. Komamura, I. Shimomura, M. Hori, Y. Matsuzawa, T. Funahashi, and M. Kitakaze Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism Cardiovasc Res, September 1, 2005; 67(4): 705 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Tauman, L. M. O'Brien, A. Ivanenko, and D. Gozal Obesity Rather Than Severity of Sleep-Disordered Breathing as the Major Determinant of Insulin Resistance and Altered Lipidemia in Snoring Children Pediatrics, July 1, 2005; 116(1): e66 - e73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Vale Psychosocial stress and cardiovascular diseases Postgrad. Med. J., July 1, 2005; 81(957): 429 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hemingway, M. Shipley, E. Brunner, A. Britton, M. Malik, and M. Marmot Does Autonomic Function Link Social Position to Coronary Risk?: The Whitehall II Study Circulation, June 14, 2005; 111(23): 3071 - 3077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. la Fleur, H. Houshyar, M. Roy, and M. F. Dallman Choice of Lard, But Not Total Lard Calories, Damps Adrenocorticotropin Responses to Restraint Endocrinology, May 1, 2005; 146(5): 2193 - 2199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Marmot and E. Brunner Cohort Profile: The Whitehall II study Int. J. Epidemiol., April 1, 2005; 34(2): 251 - 256. [Full Text] [PDF]
|
|
|
|
|
|
J. P. Curtis, J. G. Selter, Y. Wang, S. S. Rathore, I. S. Jovin, F. Jadbabaie, M. Kosiborod, E. L. Portnay, S. I. Sokol, F. Bader, et al. The Obesity Paradox: Body Mass Index and Outcomes in Patients With Heart Failure Arch Intern Med, January 10, 2005; 165(1): 55 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Huggett, J. Burns, A. F. Mackintosh, and D. A.S.G. Mary Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension Hypertension, December 1, 2004; 44(6): 847 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Daskalopoulou, D. P. Mikhailidis, and M. Elisaf Prevention and Treatment of the Metabolic Syndrome Angiology, November 1, 2004; 55(6): 589 - 612. [Abstract] [PDF]
|
|
|
|
|
|
J. P. Girod and D. J. Brotman Does altered glucocorticoid homeostasis increase cardiovascular risk? Cardiovasc Res, November 1, 2004; 64(2): 217 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Britton, M. Shipley, M. Marmot, and H. Hemingway Does access to cardiac investigation and treatment contribute to social and ethnic differences in coronary heart disease? Whitehall II prospective cohort study BMJ, August 7, 2004; 329(7461): 318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Weisbrod, P. R. Eastwood, G. O'Driscoll, J. H. Walsh, M. Best, J. R. Halliwill, and D. J. Green Vasomotor Responses to Hypoxia in Type 2 Diabetes Diabetes, August 1, 2004; 53(8): 2073 - 2078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Rutter, J. B. Meigs, L. M. Sullivan, R. B. D'Agostino Sr, and P. W.F. Wilson C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study Circulation, July 27, 2004; 110(4): 380 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Kinder, M. R. Carnethon, L. P. Palaniappan, A. C. King, and S. P. Fortmann Depression and the Metabolic Syndrome in Young Adults: Findings From the Third National Health and Nutrition Examination Survey Psychosom Med, May 1, 2004; 66(3): 316 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Seckl, N. M. Morton, K. E. Chapman, and B. R. Walker Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue Recent Prog. Horm. Res., January 1, 2004; 59(1): 359 - 393. [Abstract] [Full Text]
|
|
|
|
|
|
D. J. Brotman, J. P. Girod, L. B. Tanko, Y. Z. Bagger, P. Alexandersen, C. Christiansen, and P. J. Larsen Can Glucocorticoid Homeostasis Explain the Antiatherogenic Effect of Peripheral Adiposity? * Reply Circulation, August 26, 2003; 108 (8): e61 - e61. [Full Text] [PDF]
|
|
|
|
|
|
K. Rennie, N McCarthy, S Yazdgerdi, M Marmot, and E Brunner Association of the metabolic syndrome with both vigorous and moderate physical activity Int. J. Epidemiol., August 1, 2003; 32(4): 600 - 606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.M.V. Ward, A. Jones, and D.I.W. Phillips Stress, disease and 'joined-up' science QJM, July 1, 2003; 96(7): 463 - 464. [Full Text] [PDF]
|
|
|
|
|
|
P. Hjemdahl Stress and the Metabolic Syndrome: An Interesting but Enigmatic Association Circulation, November 19, 2002; 106(21): 2634 - 2636. [Full Text] [PDF]
|
|